Measuring the impact of MS on walking ability

By J. Hobart, A. Riazi, D. Lamping, R. Fitzpatrick, A. Thompson. Neurology, 2003

794 citations recorded by the source corpus.

Subfields: Neurology, Pathology and Forensic Medicine, Physical Therapy, Sports Therapy and Rehabilitation

View Paper: https://www.semanticscholar.org/paper/ab9ec905dde72e9c180cd109d179e8436d246f79

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pathology and Forensic Medicine

1. Jeffrey A. Cohen

Citations in the corpus

• Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis (2013, methodology): “The total MSWS-12 score is computed by summing the individual item scores, subtracting the minimum possible score (12), dividing by the maximal score (48), and then multiplying the result by 100 [23].”
• Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls (2008, background): “The MSFC is a composite measure of disability comprising quantitative tests of ambulation (Timed 25-foot walk, T25FW), arm function (Nine-hole peg test), and cognition (Paced auditory serial addition test) [16].”
• Gait Analysis Methods: An Overview of Wearable and Non-Wearable Systems, Highlighting Clinical Applications (2014, background): “This scale assesses 12 parameters, taken from interviews with 30 patients, expert opinions and literature reviews which describe the impact of multiple sclerosis on patients’ gait [21].”